Supporting a Three-Person Startup from Foundation to Acquisition
When a three-person wound care startup company approached AlvaMed, they had a promising concept and an early-stage design they believed would meet market needs. What they did not yet have was the regulatory and quality infrastructure, a quality system, or a strategic roadmap necessary to bring a medical device successfully to commercial release.
AlvaMed’s consultants were integrated directly into their organization, providing fractional executive leadership and comprehensive regulatory and quality support from early stage design control through acquisition.
Fractional Executive Leadership
To provide manpower and strategic direction, AlvaMed embedded experienced leadership into the organization:
- Diana Grenier served as Head of Quality, overseeing quality system development, compliance strategy, and audit readiness and partnering with the engineering team in design assurance.
- Eric Bannon served as Head of Regulatory, leading regulatory strategy, submission planning, and agency interactions.
This fractional leadership model allowed the startup to access senior-level expertise without the overhead of building a full internal department – while maintaining continuity and long-term strategic alignment.
Building the Foundation: Full QMS Implementation & Design Controls
AlvaMed implemented the company’s complete Quality Management System from the ground up, establishing compliant processes aligned with regulatory requirements and industry best practices. This included:
- Development and deployment of a scalable QMS compliant with FDA and 13485 requirements
- Full design control implementation
- Risk management integration
- Supplier qualification and management processes
- Document control and training systems
Through structured design reviews and rigorous design control processes, AlvaMed helped refine the product, identify critical gaps, and strengthen documentation to support regulatory clearance and long-term compliance.
Strategic Manufacturing & Development Partnership
Recognizing the importance of strong external collaboration, AlvaMed supported the client in the management of their suppliers, including oversight of their contract manufacturer. We partnered with Sage Product Development to ensure the product design was robust, manufacturable, and aligned with regulatory expectations.
This integrated approach ensured:
- Design transfer readiness
- Manufacturing scalability
- Documentation aligned with regulatory submission requirements
- Clear traceability throughout the product lifecycle
Regulatory Strategy & FDA Audit Success
AlvaMed developed and executed the company’s regulatory strategy, guiding the client through submission planning and agency engagement. Following commercial release, we supported the organization through two successful FDA audits, demonstrating the strength and sustainability of the quality system that had been built from the ground up.
The successful audits reinforced both product integrity and organizational maturity – key factors that strengthened the company’s market position.
Commercial Launch and Strategic Acquisition
With a compliant QMS, strong regulatory standing, and a successful commercial release, the company demonstrated significant value in the wound care market. Post-launch, the startup was acquired by a large multinational medical device organization.
At that stage, AlvaMed facilitated a structured and seamless transition, handing over the fully operational quality and regulatory infrastructure to the acquiring company.
Leadership Reflection
“It was incredibly rewarding to work alongside this client from the early stages of their journey – when they were just three people with a vision – and to help build the systems and structure that ultimately supported their commercial success and acquisition. Being able to hand over a mature, audit-ready organization to a multinational company was a proud moment for our entire team.”
— Diana Grenier, Vice President of Quality Compliance, AlvaMed
Outcome
- Full QMS built from scratch
- End-to-end design control implementation
- Strategic regulatory roadmap and execution
- Successful commercial release
- Two successful FDA audits
- Acquisition by a multinational medical device company
- Seamless post-acquisition transition
This engagement reflects AlvaMed’s ability to serve as a long-term partner – providing integrated quality, regulatory, and clinical leadership from early-stage development through exit.
